Streetbeat News

Revenues

BRCC

BRC Inc (NYSE:BRCC) has been analyzed by 5 analysts, showing a shift towards a more bullish outlook with an average 12-month price target of $7.35, a 27.83% increase from the previous target. The company, serving premium coffee and merchandise to military and first responders, has shown a revenue growth of 27.81% as of December 31, 2023, but struggles with profitability and debt management.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 12:00 pm

JLL

Jones Lang LaSalle (JLL) reported a significant increase in its Q1 earnings per share (EPS) to $1.78, up from $0.71 year-over-year (YoY). Additionally, JLL's revenue for the quarter rose to $5.124 billion from $4.715 billion YoY, indicating strong financial performance.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:52 am

ARKB

BITB

FBTC

GBTC

IBIT

Bitcoin spot ETFs in the U.S. saw a significant rebound with $378M in inflows on May 3rd, marking a shift from recent outflows. The Grayscale Bitcoin Trust (GBTC), Fidelity Bitcoin Trust (FBTC), BlackRock's iShares Bitcoin Trust (IBIT), Bitwise's Bitcoin ETF (BITB), and Ark's ETF (ARKB) all experienced notable inflows. This resurgence in investment coincides with a recovery in the crypto market and broader economic signals suggesting easing inflation, potentially influencing Federal Reserve policies.

Portfolio Pulse from Murtuza Merchant

May 06, 2024 | 11:40 am

GOSS

Gossamer Bio, Inc. (NASDAQ:GOSS) has entered into a $160M partnership with Chiesi Group to develop and commercialize seralutinib for pulmonary hypertension. This collaboration aims to accelerate seralutinib's development, particularly for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Gossamer will lead the development and US commercialization, sharing costs and profits with Chiesi, which will commercialize seralutinib outside the US. Gossamer could receive up to $486M in milestones.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:37 am

TSN

Tyson Foods projects its adjusted operating income for 2024 to be between $1.4 billion and $1.8 billion, with sales anticipated to remain relatively flat compared to 2023.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:31 am

LOBO

LOBO EV reported a decrease in its FY23 revenue to $15.5M from $18.3M in the previous year. Net income also fell to $0.99M from $1.12M year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:07 am

OPXS

Optex Systems has received a $3.8 million order for laser protected periscopes, indicating a significant business win for the company.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:06 am

BCRX

Biocryst has updated its 2024 revenue forecast for Orladeyo to $390M-$400M, aligning with the upper end of its previous guidance of $380M-$400M.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:05 am

THS

TreeHouse Foods projects its Q2 revenue to be between $770M and $800M, which is in line with the analyst estimate of $796.24M.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:01 am

THS

TreeHouse Foods projects its FY24 revenue to be in the range of $3.43B to $3.50B, which is around the analyst estimate of $3.45B.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:00 am